Empresa NeuroSense Therapeutics Ltd.
Acciones
NRSN
IL0011809592
Biotecnología e investigación médica
Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,3 USD | +0,78 % | -4,41 % | +65,61 % |
Resumen de negocios
Número de empleados: 18
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Alon Ben-Noon
FOU | Founder | 45 | 13/02/17 |
Or Eisenberg
DFI | Director of Finance/CFO | 42 | 01/06/21 |
Hagit Binder
COO | Chief Operating Officer | - | - |
Shiran Zimri
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/20 |
Irit Shefer
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/22 |
Ferenc Tracik
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/12/21 |
Chief Tech/Sci/R&D Officer | 63 | - | |
Diana Shtossel
LAW | General Counsel | - | 01/01/22 |
Corporate Officer/Principal | - | 01/03/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 56 | 21/12/21 | |
Chairman | 67 | 01/10/21 | |
Cary Claiborne
BRD | Director/Board Member | 64 | 01/12/21 |
Director/Board Member | 49 | 01/01/22 | |
Caren Deardorf
BRD | Director/Board Member | 59 | 21/12/21 |
Alon Ben-Noon
FOU | Founder | 45 | 13/02/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 17 334 042 | 12 382 922 ( 71,44 %) | 0 | 71,44 % |
Información de la empresa
Neurosense Therapeutics Ltd.
11 HaMenofim Street Building B
46725, Herzliya
+
http://www.neurosense-tx.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+65,61 % | 22,36 M | |
-3,16 % | 102 mil M | |
+1,74 % | 96,29 mil M | |
+2,13 % | 22,18 mil M | |
-15,64 % | 21,2 mil M | |
-9,21 % | 18,31 mil M | |
-39,98 % | 17,38 mil M | |
-14,74 % | 16,36 mil M | |
+5,78 % | 13,97 mil M | |
+32,90 % | 12,17 mil M |
- Bolsa de valores
- Acciones
- Acción NRSN
- Empresa NeuroSense Therapeutics Ltd.